Tech Company Financing Transactions
AbSci Funding Round
Casdin Capital, ArrowMark Partners and Phoenix Venture Partners joined a $65 million funding round for AbSci. The round was announced on 10/21/2020.
Transaction Overview
Company Name
Announced On
10/21/2020
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Undisclosed
Investors
Casdin Capital (Lead Investor) (Eli Casdin)
Phoenix Venture Partners (Zach Jonasson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 E 6th St. 350
Vancouver, WA 98660
USA
Vancouver, WA 98660
USA
Phone
Website
Email Address
Overview
AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean McClain
Chief Financial Officer
Gregory Schiffman
Chief Operating Officer
Andrew Pihl
Chief Technical Officer
Matthew Weinstock
VP - General Counsel
Lawrence McClure
Browse more venture capital transactions:
Prev: 10/21/2020: 4iQ venture capital transaction
Next: 10/21/2020: BrightFarms venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs